Results identify YBX3 as a key regulator of ischemic brain damage through glycolysis-dependent mechanisms and underscore its potential as a therapeutic target for stroke.
Abstract
Stroke remains one of the leading causes of death and long-term disability worldwide, with neuroinflammation and metabolic dysfunction playing central roles in its pathogenesis. In this study, we investigated the function of Y-box binding protein 3 (YBX3) in ischemic stroke, with particular focus on its regulation of glycolysis and neuroinflammatory responses. Using a middle cerebral artery occlusion (MCAO) model in C57BL/6 mice and an oxygen-glucose deprivation/reperfusion (OGD/R) model in BV2 microglia, we observed that YBX3 expression was markedly upregulated following ischemia-reperfusion. Overexpression of YBX3 aggravated cerebral infarct size, worsened motor and neurological outcomes, and increased the release of pro-inflammatory cytokines (TNF-α, IL-6, and IL-1β) both in vivo and in vitro. Mechanistically, YBX3 enhanced glycolysis in BV2 cells by stabilizing pyruvate kinase M2 (PKM2) mRNA and promoting its expression, while simultaneously activating glycolysis through the mTOR-HIF-1α signaling pathway. Pharmacological inhibition of mTOR with rapamycin reversed YBX3-induced glycolytic activation, neuroinflammation, and neuronal injury. Collectively, these results identify YBX3 as a key regulator of ischemic brain damage through glycolysis-dependent mechanisms and underscore its potential as a therapeutic target for stroke.
The results show that andrographolide promotes post-stroke vascular repair, at least in part, by regulating the interaction between brain immune cells and vascular cells, offering new insight into how this compound may support brain repair after ischemic stroke.
Hong-Fei Li, Hai-Rong Xiang, Xin-Yu Li et al.· Biology· 0 citations
BACKGROUND
Ischemic stroke remains associated with substantial neurological disability, and effective strategies for cerebral ischemia-reperfusion injury (CIRI) are limited. Dihydromyricetin (DHM) has shown neuroprotective properties in experimental neurological disorders, but its effects and associated molecular mecha...
Ying-Ying Tang, Xiao-Dan Wang, Jia-Yu Ye et al.· Phytomedicine· 0 citations
Findings indicate that TZ may protect against CIRI by suppressing apoptosis and neuroinflammation through activation of the PI3K/AKT/mTOR signaling pathway, thereby providing preclinical evidence for its potential repurposing as a treatment for ischemic stroke.
Lin-Lin Xie, Yu-Kun Ping, Jie Zhao et al.· Current Neuropharmacology· 0 citations
Findings indicate that Echinocystic acid protects against CIRI, at least in part, through a PPARγ-dependent mechanism involving promotion of microglial M2 polarization and attenuation of NLRP3/Caspase-1/GSDMD-associated pyroptotic signaling, highlighting the therapeutic potential of EA in CIRI.
Yi Zou, Hui Zhang, Jian-Xia Liu et al.· International Immunopharmaco...· 0 citations
BACKGROUND
Cerebral ischemia-reperfusion injury (CIRI) triggers endoplasmic reticulum stress (ERS), a key pathological driver of neuronal apoptosis and neurological impairment. While the neuroprotective effects of astragaloside IV (AS-IV) are well-documented, the precise regulatory bridge between the Sonic Hedgehog (SH...
Ping-Bo Wei, Yang-Yun Han, Jun Wang et al.· Brain Research· 0 citations
Elevated extracellular lactate in the acute phase of ischemic stroke drove RACs toward an A2-like phenotype through the Yes-associated protein 1 (YAP1)/STAT3/IL-10 and YAP1/SIRT1/H4K5la signaling axes.
Jun-Yuan Wei, Yu-Meng Si, Ji Li et al.· Neurobiology of Disease· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.